The pharmaceutical industry has seen an increase in the number of biologics released to fight human disease. Large molecule therapeutics requires additional consideration when developing and validating supporting methods. This webinar will address steps to consider when developing bioassays with the expectation of successful completion of validation. Specifically, this webinar covers essential concepts related to cell-based potency methods, ELISA, and other methods supporting biologics. Specific topics covered in the webinar will include cell culture, multitrack development strategies, DOE, assay variability, and the validation protocol. Attendees will receive information that should be beneficial in helping to achieve well-controlled validated bioassay methods.
Course Objectives:
• Timelines and decision points
• The importance of early planning
• Following data-driven processes
• Designing methods with validation in mind
• Use of DOE and statistical analysis
• Handling of critical materials
•
• Process monitoring concepts
• Assessing readiness for validation
• Defining the validation protocol
• Data capture and analysis during validation
• Maintaining quality through documentation
Background:
Developing and validating bioassays is a critical necessity for scientists supporting biologic development and manufacturing. Development and validation of bioassays
Why Should You Attend:
Scientists, quality
Course Outline:
• Assays required for biologics
• Timelines
• Regulatory guidance's
• Assay formats/platforms
• Standardizing cell culture procedures
• Early development - feasibility
• Use of DOE
• Involvement of statisticians
• Optimizing the assays during development
• Understanding and managing assay variability
• Validation requirements
• Written procedures (methods, protocols, SOPs)
• Analyst training
• Maintaining quality in-house and in outsourcing
What You Get:
• Training Reference Materials
• Live Q&A with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Validation Scientists
• QA
• QC
• Regulatory Affairs
• Laboratory Managers
• Assay Development Scientists
• Manufacturing Professionals
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Get Instant Access 90 Minutes View Program |
Validation Of Pharmaceutical Compressed Gasses
Get Instant Access 75 Minutes View Program |
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Drug Pharmacy Compounding
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry